Okada, Y., Takahashi, N., Takayama, T., & Goel, A. (2021). LAMC2 promotes cancer progression and gemcitabine resistance through modulation of EMT and ATP-binding cassette transporters in pancreatic ductal adenocarcinoma. Carcinogenesis.
Chicago Style CitationOkada, Yasuyuki, Naoki Takahashi, Tetsuji Takayama, and Ajay Goel. "LAMC2 Promotes Cancer Progression and Gemcitabine Resistance Through Modulation of EMT and ATP-binding Cassette Transporters in Pancreatic Ductal Adenocarcinoma." Carcinogenesis 2021.
MLA CitationOkada, Yasuyuki, Naoki Takahashi, Tetsuji Takayama, and Ajay Goel. "LAMC2 Promotes Cancer Progression and Gemcitabine Resistance Through Modulation of EMT and ATP-binding Cassette Transporters in Pancreatic Ductal Adenocarcinoma." Carcinogenesis 2021.